A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Locally Advanced or Metastatic Breast Cancer
Interventions: DRUG: Eribulin mesylate
Sponsor: Eisai Korea Inc.